Empagliflozin in HNF1A-MODY (MODY3)-a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
- Journal:
- Diabetes Care
- Published:
- DOI:
- 10.2337/dc25-2572
- Affiliations:
- 8
- Authors:
- 12
| Institutions | Authors | Share |
|---|---|---|
| Copenhagen University Hospital (CUH), Denmark | 0.50 | |
| University of Copenhagen (UCPH), Denmark | 0.33 | |
| Aarhus University (AU), Denmark | 0.08 | |
| Regional Hospital Central Jutland, Denmark | 0.04 | |
| Aarhus University Hospital, Denmark | 0.04 |